Quick Answer
Zivo Bioscience, Inc. reported Net Income of -$13.38 million for fiscal year 2024.
Zivo Bioscience, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$13.38M | -72.1% |
| 2023 | -$7.78M | +11.1% |
| 2022 | -$8.75M | +0.1% |
| 2021 | -$8.76M | +3.8% |
| 2020 | -$9.11M | +20.9% |
| 2019 | -$11.51M | +21.4% |
| 2018 | -$14.64M | -45.8% |
| 2017 | -$10.04M | -65.7% |
| 2016 | -$6.06M | -4.7% |
| 2015 | -$5.79M | -950.3% |
| 2014 | $680.8K | +106.7% |
| 2013 | -$10.10M | -210.8% |
| 2012 | -$3.25M | -18.9% |
| 2011 | -$2.73M | +61.6% |
| 2010 | -$7.12M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.03M | +54.5% | +37.0% |
| June 30, 2025 | -$1.64M | +80.1% | +61.1% |
| March 31, 2025 | -$4.21M | -229.4% | -85.6% |
| September 30, 2024 | -$2.27M | -24.3% | +72.5% |
| June 30, 2024 | -$8.24M | -297.8% | -544.2% |
| March 31, 2024 | -$1.28M | +35.2% | +29.9% |
| September 30, 2023 | -$1.82M | +9.0% | +11.9% |
| June 30, 2023 | -$2.07M | +0.1% | -4.9% |
- Zivo Bioscience, Inc. showed a decrease of -72.1% in Net Income compared to the prior fiscal year.
- Over the 2010–2024 period, Zivo Bioscience, Inc.’s net income has declined by 87.9% (from -$7.12 million to -$13.38 million).
- The most recent figure is from Zivo Bioscience, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 18, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: